Trials / Completed
CompletedNCT03382093
Personalized Feedback for Smokers With Elevated Anxiety Sensitivity
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 95 (actual)
- Sponsor
- University of Houston · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This project will develop and refine a computer-delivered integrated Personalized Feedback Intervention (PFI) that directly addresses smoking and anxiety sensitivity (AS). The PFI will focus on feedback about smoking behavior, AS, and adaptive coping strategies.
Detailed description
The primary goal of the research study is to investigate the efficacy of a brief, personalized computer-delivered transdiagnostic intervention (PFI) that addresses smoking and anxiety sensitivity (AS) to reduce smoking, increase quit attempts, reduce perceived barriers to cessation, reduce AS and negative affective symptoms, and increase adaptive coping skills compared to a smoking information only control. To address this aim, we will implement a randomized controlled trial that will employ a longitudinal experimental design and involve three stages: (a) phone-screener (pre-screener); (b) baseline appointment consisting of a pre-intervention assessment (eligibility), random assignment to a one-session computer-delivered intervention (PFI versus smoking information control with no personalized feedback), and a post-intervention assessment; (c) 1-month follow-up. Assessments will include a multi-method approach, including biological, behavioral, and self-report methods.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Personalized Feedback Intervention | Personalized Feedback Intervention for smoking and anxiety. |
| BEHAVIORAL | Smoking Information Control | Smoking Information with no personalized feedback. |
Timeline
- Start date
- 2017-08-23
- Primary completion
- 2019-06-01
- Completion
- 2019-06-01
- First posted
- 2017-12-22
- Last updated
- 2019-06-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03382093. Inclusion in this directory is not an endorsement.